Noxopharm (ASX:NOX) Beginning Cash Position : A$3.01 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Noxopharm Beginning Cash Position?

Noxopharm's Beginning Cash Position for the quarter that ended in Dec. 2023 was A$3.01 Mil.

Noxopharm's quarterly Beginning Cash Position declined from Dec. 2022 (A$13.98 Mil) to Jun. 2023 (A$11.28 Mil) and declined from Jun. 2023 (A$11.28 Mil) to Dec. 2023 (A$3.01 Mil).

Noxopharm's annual Beginning Cash Position increased from Jun. 2021 (A$7.10 Mil) to Jun. 2022 (A$26.80 Mil) but then declined from Jun. 2022 (A$26.80 Mil) to Jun. 2023 (A$14.01 Mil).

Noxopharm Beginning Cash Position Historical Data

The historical data trend for Noxopharm's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noxopharm Beginning Cash Position Chart

Noxopharm Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Beginning Cash Position

Get a 7-Day Free Trial

12.61

2.91

7.10

26.80

14.01

Noxopharm Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial										26.80	16.69	13.98	11.28	3.01

Noxopharm Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Noxopharm Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Noxopharm's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Noxopharm (ASX:NOX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noxopharm Ltd (ASX:NOX) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

NOXOF:USA

Address

60 Linksley Ave, Glenhaven, NSW, AUS, 2156

Website

https://www.noxopharm.com

Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.

Noxopharm (ASX:NOX) Headlines

No Headlines